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S U M M A R Y
Background: Illegal commercial plasma and blood donation activities in the late 1980s and early 1990s
caused a large number of hepatitis C virus (HCV) infections in rural areas of China.
Methods: A cross-sectional survey was carried out in 2008, in which all residents in a former blood
donation village in rural Hebei Province were invited for a questionnaire interview and testing for HCV
antibodies. Questionnaires were administered to collect information about their personal status and
commercial blood donation history, and HCV antibodies were tested by enzyme immunoassay.
Results: Of 520 villagers who participated in the interviews, 236 (45.4%) reported a history of selling
whole blood or plasma. HCV seropositivity was conﬁrmed in 148/520 (28.5%) interviewees and 101/236
(42.8%) former commercial plasma and blood donors. Selling plasma was the strongest independent
predictor of HCV seropositivity (p = 0.0037). Past history of an operation was also independently
associated with HCV infection (p = 0.0270).
Conclusions: Unsafe practices during illegal plasma donation led to a high risk of HCV seropositivity for
donors during the late 1980s and early 1990s. Many infected people suffered chronic hepatitis from that
time onwards and urgently needed treatment and care.
 2012 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
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Hepatitis C virus (HCV) infection occurs worldwide. It is a major
cause of chronic liver disease and the most common indication for
liver transplantation.1,2 Although the prevalence varies broadly
among geographic areas, it is estimated that there are 170 million
HCV chronic carriers globally and the prevalence rates range
between about 0.1% in countries such as Iceland and Norway to
18.1% in Egypt.3 In China, a nationwide study conducted in 1992
revealed that HCV prevalence was 3.2% in China overall and 3.1% in
rural China.4 Other smaller studies have reported HCV prevalence
rates of 0–3% in rural populations from various Chinese
provinces.5–7
-HCV is most frequently transmitted by percutaneous exposure
to infected blood or blood-derived body ﬂuids, such as through
transfusion of contaminated blood or blood products, nonsterile
medical injections, or injecting drug use.8 In China, illegal* Corresponding author. Tel.: +86 10 58900800 (S. Bi); +86 10 58900802
(Y. Zhang); fax: +86 10 58900806.
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http://dx.doi.org/10.1016/j.ijid.2012.05.1035commercial plasma and blood collection activities were very
common in the late 1980s and early 1990s before the national
blood donation law was enacted. These illegal blood donations
caused serious blood-borne HCV infections in some rural areas. The
ﬁrst recognized outbreak of HCV infection among plasma donors
occurred in the late 1980s.9 Since then, cross-sectional studies have
investigated HCV infection among former plasma or blood donors, in
whom prevalence rates have varied from 9.6% to 72.8%.10–14
In the present study, we performed a cross-sectional survey to
investigate the prevalence and risk factors among residents in a
former commercial blood donation village in Central China, where
farming is the predominant occupation. The data derived could be
used to provide basic information for the management and
treatment of HCV carriers in order to reduce the transmission of
HCV after blood donation.
2. Methods
2.1. Participants and samples
A register of all residents of the study village was obtained from
the local authorities during the preparatory study. Next, all the
local residents of this village aged 1–91 years were invited toses. Published by Elsevier Ltd. All rights reserved.
Table 1
Seroprevalence of anti-HCV in all subjects stratiﬁed by sex, age, education, and blood donation experience
Parameters Number HCV seropositivity, n (%) Chi-square value p-Value
Sex 0.3094 0.578
Male 256 70 (27.3)
Female 264 78 (29.5)
Age groups, years 21.5842 <0.0001
1–19 49 4 (8.2)
20–29 64 9 (14.1)
30–39 60 9 (15.0)
40–49 129 43 (33.3)
50–59 110 54 (49.1)
60 or older 108 29 (26.9)
Education 4.341 0.0372
Educated 380 95 (25.0)
Illiterate 140 53 (37.9)
Educational experience 0.5789 0.7487
Illiterate 140 53 (37.9)
Primary school 175 43 (24.6)
Middle school 165 42 (25.5)
High school 40 10 (25.0)
Donation 43.611 <0.0001
Donors 236 101 (42.8)
Non-donors 284 47 (16.5)
HCV, hepatitis C virus.
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was conducted in the village clinic or village committee ofﬁce.
Standardized questionnaire-based interviews sought demograph-
ic, medical, and behavioral data, including plasma/blood donation
history. Ten milliliters of venous blood was collected in a vacutainer
containing sodium heparin for HCV antibody testing. The samples
were stored at room temperature and transferred within 3 h to a
ﬁeld station for processing. Aliquots of plasma were stored at 40 8C
until they were sent on dry ice to the Chinese Center for Disease
Control and Prevention in Beijing. The study protocol was approved
by the Institute of the Chinese Academy of Medical Sciences.
2.2. Laboratory assays
We tested the plasma specimens for HCV antibody by HCV
version 3.0 enzyme immunoassay (EIA) (Ortho Diagnostics,
Raritan, NJ, USA) in accordance with the manufacturer’s instruc-
tions. Samples that were positive by HCV EIA were conﬁrmed by
HCV version 3.0 RIBA (Ortho Diagnostics).
2.3. Statistical analysis
A Chi-square test was used to calculate and compare the
prevalence of viral infections among participants with different
sociodemographic characteristics. Multivariate logistic regression
analyses were undertaken to compare factors associated with HCV
infection among all participants. The 95% conﬁdence interval (CI)Table 2
HCV seroprevalence in donors of blood and plasma
Type of donation HCV antibody 
Positive Negative
Non-donors 47 237 
Blood donation only 18 99 
Blood donation only 18 99 
Plasma donation only 4 1 
Plasma donation only 4 1 
Both donation 79 35 
Non-donors 47 237 
Both donation 79 35 
HCV, hepatitis C virus.
a p-Value calculated directly by Fisher’s bilateral exact probability test.of the prevalence was calculated based on normal approximation
to binomial distribution when that approximation held. All
statistical analyses were done using SAS software version 8.0.
3. Results
3.1. Participation rate and sociodemographics of participants
Of the 1109 villagers, 520 individuals participated in the
interviews, contributed blood samples for HCV testing, and were
thereby included in the analysis. The proportions of male and
female participants were almost equal and their age distribution
was 1–91 years. The mean age of the male participants was
45.11  19.32 years and for the female participants was
45.24  17.46 years. Non-participation was mainly because of out-
migration of the villagers for a temporary job. All participants were of
Han majority ethnicity.
3.2. Commercial plasma/blood donation history
Of the 520 participants, 236 (45.4%) had a history of selling plasma
or blood in the village, where there had been an illegal commercial
plasma collection center. The other 284 villagers had never sold
plasma or blood. Among the donors, 117 individuals had sold only
blood and ﬁve had sold only plasma. The remaining 114 had sold both
blood and plasma, and accounted for 48.3% of all donors.HCV seropositivity (%) Chi-square value p-Value
16.5 0.715 0.3978
15.4
15.4 a 0.0037a
80.0
80.0 0.26 0.6101
69.3
16.5 104.62 <0.0001
69.3
Table 3
HCV seroprevalence according to route of blood exposure
Risk factors HCV antibody Total HCV seropositivity (%) Chi-square value p-Value
Positive Negative
Blood transfusion a 0.3393a
Yes 2 3 5 40.0
No 146 369 515 28.3
Operation 4.8936 0.027
Yes 30 47 77 39.0
No 118 325 443 26.6
Acupuncture 0.046 0.8301
Yes 7 16 23 30.4
No 141 356 497 28.4
Dental extraction 0.7906 0.3739
Yes 20 40 60 33.3
No 128 332 460 27.8
Razor share 0.1833 0.6685
Yes 3 4 7 42.9
No 145 368 513 28.3
Teeth-brush share a 0.4383a
Yes 1 2 3 33.3
No 147 370 517 28.4
HCV, hepatitis C virus.
a p-Value calculated directly by Fisher’s bilateral exact probability test.
Table 4
Multivariate logistic regression analysis of risk factors
Variable p-Value OR 95% CI
Age 0.024 0.816 0.683–0.974
Plasma donation 0.035 33.200 1.284–858.446
Plasma and blood donation 0.012 34.626 2.167–553.272
Operation 0.394 1.363 0.669–2.777
OR, odds ratio; 95% CI, 95% conﬁdence interval.
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3.3.1. Seroprevalence of anti-HCV in all subjects stratiﬁed by sex, age,
education, and blood donation experience
HCV infection was detected in 148 (28.5%) of the 520 villagers;
70 were males and 78 were females. The prevalence did not differ
meaningfully by sex (Chi-square = 0.3094, p = 0.5780), however
the trend Chi-square test revealed that HCV seropositivity varied
with age. The peak HCV seropositivity occurred in the 50–59 years
age group.
Our results indicated that there was a signiﬁcant difference
between educated and illiterate villagers with regard to HCV
infection, but we found no difference with respect to the level of
education attained by those who had been educated (primary
school, middle school, or high school level); this proved that HCV
seropositivity had no relationship with educational experience.
Of the villagers who had sold blood or plasma, 101 were
infected, whereas only 47 of those who had never sold blood or
plasma were seropositive. HCV seroprevalence in donors was 2.6
times higher than in the villagers who had not sold blood or
plasma. All of the results are shown in Table 1.
3.3.2. HCV seroprevalence in donors of blood and plasma
HCV seroprevalence was higher in the donors who had sold
both blood and plasma than in those who had only sold blood.
However, there was no signiﬁcant difference in HCV infection
between the donors who had sold both blood and plasma and those
who had only sold plasma. The villagers who had only sold plasma
were more likely to have become HCV-seropositive than those who
had only sold blood. The results are shown in Table 2.
3.3.3. HCV seroprevalence according to route of blood exposure
Univariate analysis demonstrated that surgery was a greater
risk factor for HCV infection than receiving a blood transfusion,
acupuncture, dental extraction, or sharing a razor or toothbrush.
The results are shown in Table 3.
3.3.4. Multivariate logistic regression analysis of risk factors
Multivariate logistic regression analysis suggested that plasma
donation (odds ratio (OR) 33.200, 95% CI 1.284–858.446; p = 0.035)
and whole blood donation (OR 34.626, 95% CI 2.167–553.272;
p = 0.012) were highly associated with HCV seropositivity. The
results are shown in Table 4.4. Discussion
According to the national survey of HCV infection, the
average seroprevalence was 3.2%,4 which means that >40
million Chinese people were HCV-seropositive. Another epide-
miological investigation has indicated that HCV is highly
prevalent in former illegal blood and plasma donors and that
prevalence could be up to 8.2% in that population.15 In the
present study, 520 residents were selected from a former blood
donation village in Dazhang, Zhao County, Hebei Province. We
found that HCV seroprevalence was 28.5% in all villagers and
42.8% in former commercial plasma/blood donors, prevalences
that are higher than the previously reported average.15 The
increased risk of HCV infection was mainly as a result of the
illegal commercial plasma and blood collection activities in
selected rural areas. In particular, the practice of pooling blood
and reinfusing red blood cells into donors of the same blood
types caused the rapid spread of HCV infection.9
There was no difference in HCV seropositivity according to sex,
which suggests a similar sensitivity to HCV infection between men
and women. Chi-square tests revealed that HCV seropositivity
increased with age and reached a peak in the 50–59 years age
group. In contrast, HCV seroprevalence was lower in those aged
60 years than in the 50–59 years age group, because participation
in commercial blood donation mostly involved adults and
adolescents at that time. This study was performed more than
10 years after the ban on illegal commercial blood donation, and
most of the donors were aged >40 years. This could explain why
the 50–59 years age group had a relatively higher HCV
seropositivity.
Although HCV is transmitted mainly through blood-to-blood
contact and intravenous drug use is currently the dominant route
of transmission in developed countries, in China as a developing
C. Huang et al. / International Journal of Infectious Diseases 16 (2012) e731–e734e734country, nosocomial transmission of HCV is not an uncommon
route of infection and may be greatly underestimated. That is why
surgery was found to be the most important HCV risk factor in our
study by univariate analysis.
In both male and female subjects, selling plasma, older age, and
surgery appeared to be associated with HCV infection. In the
multivariate analyses to identify risk factors, selling plasma (OR
33.200; p = 0.035) and whole blood (OR 34.626; p = 0.012) were
independently associated with HCV seropositivity.
However, HCV seropositivity was 16.5% in those who had never
sold blood or plasma, which is clearly higher than the average HCV
seroprevalence in the Chinese population. This phenomenon was
probably caused by other unusual routes of HCV transmission,
such as mucosal exposure, sexual transmission, and perinatal
exposure (mother to child).16–18 For example, the spouse of an HCV
carrier was much more likely to be infected, and the child of an
HCV-infected mother was also at higher risk.
In summary, HCV is now common in this selected rural Chinese
community and the public health impact of the high prevalence of
HCV infection may be substantial. HCV is an important cause of
end-stage liver disease and hepatocellular carcinoma, and it can
act synergistically with hepatitis B virus infection,19 which is
endemic in China. Future studies should examine the prevalence of
blood-borne viruses in other parts of China, how these viruses are
transmitted, and the resulting health effects. Efforts to halt the
transmission of HCV and other blood-borne viruses in rural China
should be a top public health priority.
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